[Treatment of recurrent epistaxis in Rendu-Osler-Weber disease]
- PMID: 9417448
- DOI: 10.1007/s001060050141
[Treatment of recurrent epistaxis in Rendu-Osler-Weber disease]
Abstract
Rendu-Osler-Weber disease is an autosomally dominant inherited disease which affects the connective tissue of blood vessels. The major symptom is recurrent epistaxis for which still exists no generally recommended treatment. Treatment modalities discussed in the literature include bilateral closure of the nostrils, brachytherapy, vessel embolization, hormone therapy, dermoplasties, as well as different kinds of laser therapies. Advantages and disadvantages of single treatment modalities are discussed. Dermoplasty and laser therapy seem to be the most suitable treatment procedures currently available for recurrent epistaxis in affected patients. Treatment carried out with the argon, KTP or ND:YAG laser has proven to be suitable as initial therapy. In most cases the additional use of long-term applications of a soft nasal ointment allows a lasting successful treatment. Our experiences show that dermoplasty should be reserved for cases with continued bleeding despite laser treatment but only rarely offers a long-term cure in the sense of a total recovery from epistaxis.
Similar articles
-
[Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].HNO. 1998 Mar;46(3):228-32. doi: 10.1007/s001060050230. HNO. 1998. PMID: 9583027 German.
-
Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia.South Med J. 1996 Jan;89(1):78-80. doi: 10.1097/00007611-199601000-00014. South Med J. 1996. PMID: 8545698
-
[Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia].Laryngorhinootologie. 1997 Aug;76(8):495-501. doi: 10.1055/s-2007-997467. Laryngorhinootologie. 1997. PMID: 9376034 German.
-
[Nasal cavity dermoplasty as a treatment of recurrent bleeding in Rendu-Osler-Weber's disease].Otolaryngol Pol. 2007;61(1):74-9. doi: 10.1016/s0030-6657(07)70387-6. Otolaryngol Pol. 2007. PMID: 17605423 Review. Polish.
-
Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.Lasers Surg Med. 2020 Apr;52(4):293-300. doi: 10.1002/lsm.23147. Epub 2019 Aug 22. Lasers Surg Med. 2020. PMID: 31441079 Free PMC article.
Cited by
-
[Epistaxis-overview and current aspects].HNO. 2021 Nov;69(11):931-942. doi: 10.1007/s00106-021-01110-4. Epub 2021 Oct 13. HNO. 2021. PMID: 34643746 German.
-
Trauma Can Induce Telangiectases in Hereditary Hemorrhagic Telangiectasia.J Clin Med. 2020 May 17;9(5):1507. doi: 10.3390/jcm9051507. J Clin Med. 2020. PMID: 32429545 Free PMC article.
-
Life-threatening bleeding after tooth extraction due to vascular malformation: a case report and literature review.Oral Maxillofac Surg. 2014 Sep;18(3):279-82. doi: 10.1007/s10006-014-0448-3. Epub 2014 Apr 23. Oral Maxillofac Surg. 2014. PMID: 24756853 Review.
-
Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point of View.Clin Exp Otorhinolaryngol. 2017 Jun;10(2):153-157. doi: 10.21053/ceo.2016.00318. Epub 2016 Jul 21. Clin Exp Otorhinolaryngol. 2017. PMID: 27440131 Free PMC article.
-
The value of screening for multiple arterio-venous malformations in hereditary hemorrhagic telangiectasia: a diagnostic study.Eur Arch Otorhinolaryngol. 2004 Oct;261(9):509-16. doi: 10.1007/s00405-003-0719-3. Epub 2003 Dec 17. Eur Arch Otorhinolaryngol. 2004. PMID: 14685882
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources